Peter DiLaura is an accomplished biotechnology executive with over 25 years of experience in the life sciences industry. Currently, they serve as President and CEO of Initial Therapeutics and hold the position of Strategic Advisor for Innovation Endeavors' Engineering Health Portfolio. Peter has previously held key roles such as Chief Business and Strategy Officer, President & CEO of Second Genome, and Senior Vice President at Ingenuity Systems. They also have experience as an Independent Board Director at Character Biosciences and Strategic Advisor at the Dementia Discovery Fund and Third Rock Ventures. Peter earned a BS in Economics from the University of Pennsylvania.
This person is not in the org chart
This person is not in any teams
This person is not in any offices